Bladder Outlet Obstruction: Clinical Trials

3 trials for Bladder Outlet Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1
Phase 11Unknown 1

Follow Bladder Outlet Obstruction: new trials by email Literature Review of Bladder Outlet Obstruction trials Research Report on Bladder Outlet Obstruction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture
Liposuction, Transurethral bladder neck resection., ADRC - Bladder Neck Obstruction, Bladder Outlet Obstruction
Phase 1 / Phase 2UnknownCentral Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation122016-01-012016-08-16
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
solifenacin succinate, tamsulosin hydrochloride, Placebo to solifenacin - Lower Urinary Tract Symptoms, Bladder Outlet Obstruction
Phase 2CompletedAstellas Pharma Inc2222007-06-012014-08-06
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Mirabegron, Placebo - Lower Urinary Tract Symptoms, Bladder Outlet Obstruction
Phase 2CompletedAstellas Pharma Inc2002006-12-012014-04-04

Narrower conditions

Urinary Bladder Neck Obstruction (3)  ·  Lower Urinary Tract Symptoms (2)  ·  Multiple Endocrine Neoplasia Type 1 (1)  ·  Prostatic Hyperplasia (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Male Urogenital Diseases (3)  ·  Urethral Diseases (3)  ·  Urethral Obstruction (3)  ·  Urinary Bladder Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Urological Manifestations (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Genetic Diseases, Inborn (1)

Interventions

Lipectomy (1)  ·  Solifenacin Succinate (1)  ·  Tamsulosin (1)  ·  mirabegron (1)

Sponsors

Astellas Pharma Inc (2)  ·  Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1)

Countries

United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Poland (1)  ·  Russia (1)

Top investigators

Andrey A Pulin, MD, PhD (1)  ·  Andrey Z Vinarov, MD, PhD, Prof (1)  ·  Denis V Butnaru, MD, PhD (1)

Results publications

PMID 22831853